Skip to Content

Biolidics Ltd Ordinary Shares 8YY Stock Quote

| Rating as of

Morningstar‘s Stock Analysis 8YY

Currency in SGD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics 8YY

Company Profile 8YY

Business Description

Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics related industrial design services and investment holding. Its segments include Cancer; Infectious diseases; and Laboratory services. It derives major revenue from the infectious diseases segment that involves the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship network and direct customers in the infectious diseases field. Its operations are spread across Singapore, Japan, China, Europe, United States, Hong Kong, Philippines, Indonesia, and Others.

37 Jalan Pemimpin, No. 02-07 Mapex
Singapore, 577177, Singapore
T +65 64820668
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Dec 31, 2022
Employees 26